Article Versions Notes

Wendlinger S, Wohlfarth J, Siedel C, Kreft S, Kilian T, Junker S, Schmid L, Sinnberg T, Dischinger U, Heppt MV, et al. Susceptibility of Melanoma Cells to Targeted Therapy Correlates with Protection by Blood Neutrophils. Cancers. 2024; 16(9):1767. https://doi.org/10.3390/cancers16091767

Wendlinger, Simone, Jonas Wohlfarth, Claudia Siedel, Sophia Kreft, Teresa Kilian, Sarah Junker, Luisa Schmid, Tobias Sinnberg, Ulrich Dischinger, Markus V. Heppt, and et al. 2024. "Susceptibility of Melanoma Cells to Targeted Therapy Correlates with Protection by Blood Neutrophils" Cancers 16, no. 9: 1767. https://doi.org/10.3390/cancers16091767

Wendlinger, S., Wohlfarth, J., Siedel, C., Kreft, S., Kilian, T., Junker, S., Schmid, L., Sinnberg, T., Dischinger, U., Heppt, M. V., Wistuba-Hamprecht, K., Meier, F., Erpenbeck, L., Neubert, E., Goebeler, M., Gesierich, A., Schrama, D., Kosnopfel, C., & Schilling, B. (2024). Susceptibility of Melanoma Cells to Targeted Therapy Correlates with Protection by Blood Neutrophils. Cancers, 16(9), 1767. https://doi.org/10.3390/cancers16091767